Merit Medical Systems, Inc. has announced the appointment of Martha Aronson as the new President and Chief Executive Officer, effective October 3, 2025. Fred P. Lampropoulos will continue to serve as the Chairman of the Board, President, and CEO until that date. Aronson brings extensive experience in global healthcare, having overseen global healthcare businesses ranging from $500 million to $1 billion. She has held executive positions at Ecolab, Inc., Hill-Rom Holdings, Inc., and spent nearly 20 years at Medtronic.
The company also released preliminary unaudited revenue figures for the quarter ended June 30, 2025, indicating a projected increase of approximately 12% to 14% compared to the same period in 2024. The preliminary constant currency revenue for the quarter increased in the range of approximately 11% to 13% compared to the prior year period.
The company plans to release its financial results for the quarter ended June 30, 2025, after the close of the stock market on Wednesday, July 30, 2025. Merit also plans to hold its investor conference call on the same day at 5:00 p.m. Eastern Time.
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures. The company serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals and employs approximately 7,300 people worldwide. As a result of these announcements, the company's shares have moved -1.76% on the market, and are now trading at a price of $93.49. Check out the company's full 8-K submission here.
